# OnCo record paper-epcoritamab-dlbcl-blood-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-epcoritamab-dlbcl-blood-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-epcoritamab-dlbcl-blood-2025" ;
  schema:name "Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial"@en ;
  schema:description "Phase 2 or 3 results paper on Epcoritamab in Diffuse large B-cell lymphoma, in Blood (2025), one of the most cited Europe PMC records with Epcoritamab in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-epcoritamab-dlbcl-blood-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood.2024026830>, <https://pubmed.ncbi.nlm.nih.gov/39792928/>, <https://europepmc.org/article/MED/39792928>, <https://clinicaltrials.gov/study/NCT04663347> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1182/blood.2024026830> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Brody JD, Jørgensen J, Belada D, et al." ;
  onco:trials <https://onco.cc/trials/nct04663347/> ;
  onco:journals <https://onco.cc/journals/blood/> .